Dakota Wealth Management Organon & Co. Transaction History

Dakota Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	SELL	$8.04 - $14.72 $266,526 - $487,968	-33,150 Reduced 68.0%	15,603 $151,000
Q1 2025 May 01, 2025	SELL	$14.29 - $16.41 $14,361 - $16,492	-1,005 Reduced 2.02%	48,753 $725,000
Q4 2024 Jan 17, 2025	SELL	$14.44 - $18.83 $12,071 - $15,741	-836 Reduced 1.65%	49,758 $742,000
Q3 2024 Oct 23, 2024	SELL	$18.65 - $23.03 $48,378 - $59,739	-2,594 Reduced 4.88%	50,594 $967,000
Q2 2024 Jul 19, 2024	SELL	$17.45 - $21.96 $523 - $658	-30 Reduced 0.06%	53,188 $1.1 Million

Q1 2024 Apr 24, 2024	BUY	$13.78 - $18.8 $733,344 - $1 Million	53,218 New	53,218 $1 Million

790

197M

2.5M

2.94M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $1.92B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Dakota Wealth Management with notifications on news.